Soru

Zorluk: OrtaHemodynamic and Coagulation Processes

A 38-year-old woman is admitted to the intensive care unit with profound hypotension, widespread purpuric skin lesions, and persistent oozing from her intravenous catheter sites following an emergency dilation and curettage for a septic abortion. Laboratory studies reveal a platelet count of 22,000/mm322,000/\text{mm}^3, a significantly prolonged prothrombin time, a decreased fibrinogen level, and a markedly elevated D-dimer. Arrange the pathophysiologic events underlying this patient's hematologic and hemodynamic collapse in the correct chronological sequence, from the initial trigger to the final clinical manifestation.

  1. 1Endothelial damage and systemic cytokine release upregulate vascular tissue factor expression.
  2. 2Unregulated activation of the extrinsic coagulation cascade leads to massive systemic thrombin generation.
  3. 3Widespread fibrin deposition in the microvasculature causes tissue ischemia and microangiopathic hemolysis.
  4. 4Ongoing intravascular thrombosis results in the profound consumption of platelets and circulating coagulation factors.
  5. 5Secondary activation of plasmin degrades cross-linked fibrin, producing fibrin degradation products and exacerbating the bleeding diathesis.

Cevap

The correct pathophysiologic sequence begins with the inflammatory upregulation of tissue factor, which triggers the extrinsic pathway leading to systemic thrombin generation. This causes widespread microvascular fibrin deposition, subsequently leading to the consumptive depletion of platelets and coagulation factors, and finally concluding with the secondary plasmin-mediated fibrinolysis that produces D-dimers and worsens the severe bleeding.
Disseminated intravascular coagulation (DIC) is characterized by an initial systemic procoagulant phase followed by a consumptive hemorrhagic phase. The sequence strictly begins with an inciting trigger (endothelial injury and tissue factor release), leading to uninhibited thrombin generation. Thrombin drives the formation of fibrin microthrombi (causing ischemia). The extensive creation of these clots consumes the available pool of platelets and coagulation factors. Finally, the body's endogenous fibrinolytic system (plasmin) breaks down these clots, elevating D-dimer levels and contributing to the bleeding diathesis via the inhibitory effects of fibrin degradation products.

Adım Adım Çözüm

1
Identify the inciting event triggering the coagulation cascade.
Systemic inflammation (sepsis) causes endothelial damage and upregulates tissue factor.
Sepsis induces a cytokine storm that alters the normally antithrombotic endothelial surface to a prothrombotic state by exposing tissue factor to the bloodstream.
2
Determine the immediate biochemical consequence of tissue factor exposure.
Activation of the extrinsic pathway and massive thrombin generation.
Tissue factor is the primary physiologic initiator of coagulation; its widespread exposure leads to uncontrolled thrombin production.
3
Trace the direct effect of unregulated thrombin in the circulation.
Conversion of fibrinogen to fibrin, resulting in microvascular thrombosis.
Thrombin acts on fibrinogen to form fibrin meshes, which lodge in small vessels, leading to ischemia and red blood cell shearing (schistocytes).
4
Identify the mechanism behind the onset of the bleeding diathesis.
Profound consumption of platelets and coagulation factors.
Because the coagulation cascade is continuously activated systemically, the body's stores of platelets and soluble clotting factors are rapidly depleted.
5
Determine the counter-regulatory response and its clinical effect.
Secondary fibrinolysis generates fibrin degradation products (FDPs) like D-dimer.
Plasmin attempts to clear the widespread clots but generates FDPs, which interfere with further fibrin polymerization and platelet function, worsening the hemorrhage.

Anahtar Kavram

Pathophysiology and temporal sequence of Disseminated Intravascular Coagulation (DIC)
Bu soruyu puanla